Total planned funding: $569,962,517
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $82,455,213 |
Nigeria | $68,403,827 |
Zambia | $66,825,907 |
South Africa | $61,060,120 |
Asia Regional Program | $35,475,616 |
Tanzania | $32,638,530 |
Vietnam | $23,950,307 |
Ethiopia | $21,508,412 |
Kenya | $21,459,794 |
Burundi | $19,117,166 |
Zimbabwe | $18,045,078 |
Rwanda | $16,736,398 |
Haiti | $15,157,217 |
West Africa Region | $13,460,980 |
Cambodia | $9,950,000 |
Malawi | $8,149,263 |
Dominican Republic | $7,551,779 |
enumerations.Philippines | $6,341,584 |
Côte d'Ivoire | $5,969,001 |
Democratic Republic of the Congo | $4,658,301 |
Botswana | $4,340,020 |
Lesotho | $4,045,857 |
Uganda | $3,955,454 |
India | $3,577,954 |
Eswatini | $3,490,687 |
South Sudan | $3,430,000 |
Indonesia | $3,380,435 |
China | $2,350,000 |
Ghana | $1,290,000 |
Western Hemisphere Region | $709,018 |
Thailand | $478,599 |
Organizational Types
NGO | $554,641,080 |
Implementing Agency | $15,321,437 |
Program Areas
Care | $166,364,916 |
Prevention | $165,274,978 |
Treatment | $136,250,222 |
Testing | $57,293,743 |
Governance and Systems | $44,778,658 |
Budget Codes
HTXS: Treatment: Adult Treatment | $116,563,251 |
HKID: Care: Orphans and Vulnerable Children | $91,575,598 |
HVOP: Sexual Prevention: Other Sexual Prevention | $81,160,167 |
HVCT: Testing: HIV Testing and Counseling | $57,293,743 |
HBHC: Care: Adult Care and Support | $52,643,401 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,775,316 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $28,597,288 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,535,692 |
HLAB: Laboratory Infrastructure | $16,937,694 |
HVSI: Strategic Information | $15,626,126 |
HVTB: Care: TB/HIV | $12,542,337 |
OHSS: Health Systems Strengthening | $12,214,838 |
PDTX: Treatment: Pediatric Treatment | $11,181,573 |
PDCS: Care: Pediatric Care and Support | $9,603,580 |
HTXD: Treatment: ARV Drugs | $8,505,398 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,644,538 |
HMIN: Biomedical Prevention: Injection Safety | $413,974 |
HMBL: Biomedical Prevention: Blood Safety | $148,003 |